Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ingredio is a private Greek digital health and consumer healthtech company that offers a mobile application for scanning ingredient labels on food and cosmetic products. The app uses image capture and database-driven analysis to classify ingredients and provide users with hazard, toxicity, allergen, and natural-origin information drawn from peer-reviewed sources and institutional databases. Its focus is on helping consumers make more informed purchasing decisions around nutrition, cosmetics, and chemical exposure rather than developing therapeutics. The company appears to operate commercially as a software platform and has participated in accelerator and grant programs in Greece and Europe. Ingredio is healthcare-adjacent rather than a biotech or pharmaceutical drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ingredio.